CDER Report Adds To New FDA Research Agenda

Law360, New York (July 25, 2011, 7:22 PM EDT) -- The U.S. Food and Drug Administration's Center for Drug and Evaluation Research on Monday released a draft report highlighting major areas of scientific need aimed at helping the agency craft a strategic science and research agenda.

The report, titled “Identifying CDER's Science and Research Needs,” described seven categories of concern — including the need for improved access to post-market data sources, improved clinical trials and enhanced individualization of patient treatment — most commonly cited in interviews with more than 200 CDER employees.

The draft report will...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.